| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8736351 | Autoimmunity Reviews | 2018 | 25 Pages |
Abstract
Overall survival of SNV patients has improved since the 1980s with the decrease of vasculitis- and cardiovascular-related deaths, but cancer-related mortality remained stable. These results highlight malignancy as the current target to improve the overall prognosis.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sabine Jardel, Xavier Puéchal, Alain Le Quellec, Christian Pagnoux, Mohamed Hamidou, François Maurier, Olivier Aumaitre, Achille Aouba, Thomas Quemeneur, Jean-François Subra, Vincent Cottin, Jean Sibilia, Pascal Godmer, Patrice Cacoub,